News
Pfizer/BioNTech's COVID-19 vaccine neutralises virus in early study
Pfizer and BioNTech have announced early results from their ongoing …
21098 items found
News
Novartis pays $678 million to settle US kickback allegations
Another nail has been hammered into the coffin of the pharma model of …
News
Amgen wins latest round in legal tussle over Enbrel patents
Amgen’s reputation as a fearsome adversary in the courtroom remains …
News
Survey shows patients wait six times longer than EU neighbours for new drugs
Patients in some European countries are waiting up to six times …
Partner Content
Partner Content
News
US Congress faces pressure to maintain telehealth after COVID-19
The coronavirus pandemic has forced healthcare systems around the …
News
Bharat Biotech begins trial of COVID-19 vaccine in India as cases mount
Bharat Biotech is to begin trials of a coronavirus vaccine in …
R&D
Amgen and science education: the pharmaphorum podcast
Harvard University launched LabXchange in January and the free …
News
Celebrations as NHS England agrees deal for Vertex’ cystic fibrosis triple
NHS England has agreed a deal with Vertex for its three-drug cystic …
Views & Analysis
Unlocking the healing power of music
Continuing our series on how digital health is fighting back against …
News
US government buys most of world's supply of COVID-19 drug remdesivir
The US government has acquired most of the global supply of Gilead’s …
News
Indivior ex-CEO could face jail time after opioid conviction
The resignation of Indivior chief executive Shaun Thaxter this week …
R&D
Built for one: The case for custom formulation in the era of...
The precision medicine market is projected to exceed $175 billion by 2030, reflecting continued growth and interest in innovative approaches that tailor therapeutics that accounts for diffe
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
